Skip to main content
. 2019 Oct 21;25(39):6006–6015. doi: 10.3748/wjg.v25.i39.6006

Table 1.

Patient characteristics

Parameters AP (n = 21) No AP (n = 198) P value
Age (yr), mean ± SD 55.6 ± 16.4 61.2 ± 10.5 0.137
Male, n (%) 13 (61.9) 128 (64.6) 0.803
Cause of acute pancreatitis n (%)
ERCP 5 (23.8)
Alcoholic 9 (42.9)
Unknown 8 (33.3)
Time to surgery (d), mean ± SD 41.4 ± 10.7 10.8 ± 5.8 < 0.001
Tumor site, (head) n (%) 14 (66.7) 149 (75.3) 0.391
Positive lymph nodes, n (%) 9 (42.9) 82 (41.4) 0.898
TNM Stage, n (%) 1.000
I 2 (9.5) 18 (9.1)
II 19 (90.5) 180 (90.9)
Surgical margin (R1), n (%) 2 (9.5) 13 (6.6) 0.955
Perineural invasion, n (%) 5 (23.8) 65 (32.8) 0.399
Vascular invasion, n (%) 2 (9.5) 20 (10.1) 1.000
Differentiation, n (%) 0.283
Well 0 (0.0) 12 (6.1)
Moderate 16 (76.2) 145 (73.2)
Poor 5 (23.8) 41 (20.7)
Medical complications n (%) 7 (33.3) 59 (29.8) 0.737
Pancreatic fstula n (%)
biochemical leak 3 (14.3) 10 (5.1) 0.223
Grade B/C 3 (14.3) 9 (4.5) 0.174
Grade B 2 (9.5) 7 (3.5) 0.461
Grade C 1 (4.8) 2 (1.0) 0.675
Adjuvant Chemotherapy, n (%) 7 (33.3) 49 (24.7) 0.391
Early recurrence, n (%) 15/21 (71.4) 68/165 (41.2) 0.009
DFS, median (95%CI) 8.4 (6.7-10.1) 14.6 (10.7-18.5) 0.007
OS, median (95%CI) 14.9 (12.5-17.3) 22.3 (17.9-26.7) < 0.001

TNM: Tumor node metastasis; DFS: Disease-free survival; OS: Overall survival; AP: Acute pancreatitis; SD: Standard deviation; ERCP: Endoscopic retrograde cholangiopancreatography.